Clinical Electrophysiology in Quinine Induced Retinal Toxicity

Optometry and Vision Science

Volumn 85, Issue 1, 2008, Pages E17-E26

  Verdon, Wayne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Electroretinogram; Multifocal ERG; Quinine; Retinal toxicity

Indexed keywords

COHERENT LIGHT; DISEASE CONTROL; ELECTRONEGATIVITY; TOXICITY;

ELECTRORETINOGRAM; MULTIFOCAL ERG; QUININE; RETINAL TOXICITY;

ELECTROPHYSIOLOGY;

QUININE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG OVERDOSE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; LEG CRAMP; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA; RETINA DISEASE; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; WAVEFORM;

ANALGESICS, NON-NARCOTIC; DIAGNOSIS, DIFFERENTIAL; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; QUININE; RETINA; RETINAL DISEASES; SEVERITY OF ILLNESS INDEX; SUICIDE, ATTEMPTED; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 37849002181     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0b013e31815ed769     Document Type: Article

References (48)

1. Henry JA. Specific problems of drug intoxication. Br J Anaesth 1986;58:223-33.
2. Townend BS, Sturm JW, Whyte S. Quinine associated blindness. Aust Fam Physician 2004;33:627-8.
3. Prasad RS, Kodali VR, Khuraijam GS, Cho M, Travers JP. Acute confusion and blindness from quinine toxicity. Eur J Emerg Med 2003;10:353-6.
4. Langford NJ, Good AM, Laing WJ, Bateman DN. Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a continuing problem. Br J Clin Pharmacol 2003;56:576-8.
5. Canning CR, Hague S. Ocular quinine toxicity. Br J Ophthalmol 1988;72:23-6.
6. Zahn JR, Brinton GF, Norton E. Ocular quinine toxicity followed by electroretinogram, electro-oculogram, and pattern visually evoked potential. Am J Optom Physiol Opt 1981;58:492-8.
7. Brinton GS, Norton EW, Zahn JR, Knighton RW. Ocular quinine toxicity. Am J Ophthalmol 1980;90:403-10.
8. Tridgell DE. Quinine-induced blindness during attempted heroin withdrawal. Med J Aust 1999;171:444-446.
9. Hall AP, Williams SC, Rajkumar KN, Galloway NR. Quinine induced blindness. Br J Ophthalmol 1997;81:1029.
10. Wolf LR, Otten EJ, Spadafora MP. Cinchonism: two case reports and review of acute quinine toxicity and treatment. J Emerg Med 1992;10:295-301.
11. Dyson EH, Proudfoot AT, Prescott LF, Heyworth R. Death and blindness due to overdose of quinine. Br Med J (Clin Res Ed) 1985;291:31-3.
12. Drance SM. Quinine amaurosis. Br J Ophthalmol 1955;39:178-81.
13. Francois J, De Rouck A, Cambie E. Visual functions in quinine poisoning. Vision Res 1971;11:1218.
14. Moss HK, Herrmann LG. The use of quinine for relief of night cramps in the extremities. JAMA 1940;115:1358-9.
15. Mirghani RA, Hellgren U, Bertilsson L, Gustafsson LL, Ericsson O. Metabolism and elimination of quinine in healthy volunteers. Eur J Clin Pharmacol 2003;59:423-7.
16. Verdon WA, Haegerstrom-Portnoy G. Topography of the multifocal electroretinogram. Doc Ophthalmol 1998;95:73-90.
17. Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MO. ‘On’ response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 1992;33:477-83.
18. Renner AB, Kellner U, Cropp E, Foerster MH. Dysfunction of transmission in the inner retina: incidence and clinical causes of negative electroretinogram. Graefes Arch Clin Exp Ophthalmol 2006;244:1467-73.
19. Weleber RG, Francis PJ. Differential diagnosis of the electronegative electroretinogram. In: Heckenlively JR, Arden GB, eds. Principles and Practice of Clinical Electrophysiology of Vision, 2nd ed. Cambridge, MA: MIT Press; 2006:809-22.
20. Holder GE. Quinine retinopathy. In: Heckenlively JR, Arden GB, eds. Principles and Practice of Clinical Electrophysiology of Vision, 2nd ed. Cambridge, MA: MIT Press; 2006:841-2.
21. Francois J, De Rouck A, Cambie E. Retinal and optic evaluation in quinine poisoning. Ann Ophthalmol 1972;4:177-85.
22. Smith HE. Quinine amaurosis. Trans Ophthalmol Soc U K. 1919;39:310-6.
23. Dyson EH, Proudfoot AT, Bateman DN. Quinine amblyopia: is current management appropriate? J Toxicol Clin Toxicol 1985;23:571-8.
24. Falkenberry SM, Ip MS, Blodi BA, Gunther JB. Optical coherence tomography findings in central retinal artery occlusion. Ophthalmic Surg Lasers Imaging 2006;37:502-5.
25. Glaser BM, D’Amore PA, Michels RG, Patz A, Fenselau A. Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol 1980;84:298-304.
26. Weiter JJ, Zuckerman R. The influence of the photoreceptor-RPE complex on the inner retina. An explanation for the beneficial effects of photocoagulation. Ophthalmology 1980;87:1133-9.
27. Walden J, Speckmann EJ. Effects of quinine on membrane potential and membrane currents in identified neurons of Helix pomatia. Neurosci Lett 1981;27:139-43.
28. Malchow RP, Qian H, Ripps H. A novel action of quinine and quinidine on the membrane conductance of neurons from the vertebrate retina. J Gen Physiol 1994;104:1039-55.
29. Dixon DB, Takahashi K, Bieda M, Copenhagen DR. Quinine, intracellular pH and modulation of hemi-gap junctions in catfish horizontal cells. Vision Res 1996;36:3925-31.
30. Skatchkov SN, Eaton MJ, Shuba YM, Kucheryavykh YV, Derst C, Veh RW, Wurm A, Iandiev I, Pannicke T, Bringmann A, Reichenbach A. Tandem-pore domain potassium channels are functionally expressed in retinal (Muller) glial cells. Glia 2006;53:266-76.
31. Srinivas M, Hopperstad MG, Spray DC. Quinine blocks specific gap junction channel subtypes. Proc Natl Acad Sci U S A 2001;98:10942-7.
32. Schubert T, Degen J, Willecke K, Hormuzdi SG, Monyer H, Weiler R. Connexin36 mediates gap junctional coupling of alpha-ganglion cells in mouse retina. J Comp Neurol 2005;485:191-201.
33. Ballestero JA, Plazas PV, Kracun S, Gomez-Casati ME, Taranda J, Rothlin CV, Katz E, Millar NS, Elgoyhen AB. Effects of quinine, quinidine, and chloroquine on alpha9alpha10 nicotinic cholinergic receptors. Mol Pharmacol 2005;68:822-9.
34. Masland RH, Tauchi M. The cholinergic amacrine cell. Trends Neurosci 1986;9:218-23.
35. Granit R. The components of the retinal action potential in mammals and their relation to the discharge in the optic nerve. J Physiol 1933;77:207-39.
36. Bacon P, Spalton DJ, Smith SE. Blindness from quinine toxicity. Br J Ophthalmol 1988;72:219-24.
37. Moloney JB, Hillery M, Fenton M. Two year electrophysiology follow-up in quinine amblyopia. A case report. Acta Ophthalmol (Copenh) 1987;65:731-4.
38. Henkes HE, Deutman AF. Electrodiagnostic procedures in drug-induced ocular diseases. Doc Ophthalmol 1973;34:209-19.
39. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2002;109:1377-82.
40. Seeman JI. The Woodward-Doering/Rabe-Kindler total synthesis of quinine: setting the record straight. Angew Chem Int Ed Engl 2007;46:1378-413.
41. Stork G, Niu D, Fujimoto RA, Koft ER, Balkovec JM, Tata JR, Dake GR. The first stereoselective total synthesis of quinine. J Am Chem Soc 2001;123:3239-42.
42. Nkhoma S, Molyneux M, Ward S. in vitro antimalarial susceptibility profile and prcrt/pfmdr-1 genotypes of Plasmodium falciparum field isolates from Malawi. Am J Trop Med Hyg 2007;76:1107-12.
43. U.S. Food and Drug Administration. FDA News: FDA advances effort against marketed unapproved drugs. FDA orders unapproved quinine drugs from the market and cautions consumers about “Off-Label” use of quinine to treat leg cramps. December 11, 2006 Available at: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01521.html. Accessed September 13, 2007.
44. Man-Son-Hing M, Wells G, Lau A. Quinine for nocturnal leg cramps: a meta-analysis including unpublished data. J Gen Intern Med 1998;13:600-6.
45. Diener HC, Dethlefsen U, Dethlefsen-Gruber S, Verbeek P. Effectiveness of quinine in treating muscle cramps: a double-blind, placebo-controlled, parallel-group, multicentre trial. Int J Clin Pract 2002;56:243-6.
46. MEDSAFE. New Zealand medicines and medical devices safety authority. Medicine Adverse Reactions Committee meeting minutes. Quinine, nocturnal leg cramps and thrombocytopenia. September 2006. Available from: http://www.medsafe.govt.nz/Profs/adverse/Minutes127.htm#3.1. Accessed September 13, 2007.
47. Australian Government. Department of Health and Ageing Therapeutic Goods Administration. Australian Adverse Drug Reaction Bulletin. Quinine indications—cramps deleted. Available at: http://www.tga.gov.au/adr/aadrb/aadr0410.htm. Accessed September 13, 2007.
48. National Library for Health: Clinical Knowledge Summaries. Leg cramps—unknown cause. Prodigy guidance. November 2005. Available at: http://www.cks.library.nhs.uk/leg_cramps/in_depth/management_issues. Accessed September 13, 2007.